血红素加氧酶-1与肿瘤的研究进展

doi:10.11904/j.issn.1002-3070.2015.05.020

摘要/Abstract

摘要： 血红素加氧酶-1(HO-1)是一种重要的抗炎、抗凋亡、抗氧化及耐药相关基因。在生理状态下,人体正常组织中的HO-1蛋白呈低表达。在遭受酒精、辛辣及热烫等持续刺激时,其表达升高。HO-1的表达异常与肿瘤的生物学行为密切相关。近年来研究发现,其基因多态性及分解血红素产生的代谢产物(胆红素、Fe²⁺、CO)参与的多条信号通路的激活,并影响多种肿瘤疾病的发生、发展。另外,在许多肿瘤中HO-1表达水平上调,不仅影响肿瘤微环境中氧化应激水平对肿瘤细胞生长及增殖的调节,而且还能诱导肿瘤细胞产生耐药性。因此,HO-1表达异常可能参与了肿瘤的发生发展。

关键词: 肿瘤, 血红素加氧酶-1, 血红素, 氧化还原水平

Abstract: Heme oxygenase-1(HO-1)is a type of stress related gene,which harbors the ability of anti-inflammatory,anti-apoptosis,anti-oxidation and drug resistance.In physiological status,the expression of HO-1 gene in human normal tissues is extremely low.When subjected to a constant stimulation of alcohol,spicy and hot,over expression of HO-1 gene in the related tissues is often observed.In tumor tissues,the abnormal expression of HO-1 is closely related to their biological behaviors.In recent years,there is a trend to believe that the gene polymorphism and its metabolic products(bilirubin,Fe²⁺,CO)involve in the decomposition of heme participate in the activation of many signaling pathways,and affect the initiation and development of tumor diseases.In addition,the expression level of HO-1 gene is up-regulated in many tumor diseases,which can not only affect the growth and proliferation of tumor cells by regulation of the oxidative stress levels of tumor microenvironments,but also induce the tumor cells to produce drug resistance.Therefore,the abnormal expression of HO-1 may be involved in the initiation and development processes of tumors.

Key words: Neoplasm, HO-1, Heme, Redox level

中图分类号:

R735

任全广, 杨盛力综述, 胡建莉审校. 血红素加氧酶-1与肿瘤的研究进展[J]. 实用肿瘤学杂志, 2015, 29(5): 476-480.

REN Quanguang, YANG Shengli, HU Jianli. Heme oxygenase-1 and research progress in tumor[J]. PRACTICAL ONCOLOGY JOURNAL, 2015, 29(5): 476-480.

参考文献

1 Yin Y,Liu Q,Wang B,et al.Expression and function of heme oxygenase-1 in human gastric cancer[J].Exp Biol Med(Maywood),2012,237(4):362-371.
2 Degese MS,Mendizabal JE,Gandini NA,et al.Expression of heme oxygenase-1 in non-small cell lung cancer(NSCLC)and its correlation with clinical data[J].Lung Cancer,2012,77(1):168-175.
3 Noh SJ,Bae JS,Jamiyandorj U,et al.Expression of nerve growth factor and heme oxygenase-1 predict poor survival of breast carcinoma patients[J].BMC Cancer,2013,13:516.
4 Yin H,Fang J,Liao L,et al.Upregulation of heme oxygenase-1 in colorectal cancer patients with increased circulation carbon monoxide levels,potentially affects chemotherapeutic sensitivity[J].BMC Cancer,2014,14:436.
5 Chau LY.Heme oxygenase-1:emerging target of cancer therapy[J].J Biomed Sci,2015,22(1):22-27.
6 Chang KW,Lee TC,Yeh WI,et al.Polymorphism in heme oxygenase-1(HO-1)promoter is related to the risk of oral squamous cell carcinoma occurring on male areca chewers[J].Br J Cancer,2004,91(8):1551-1555.
7 Lo SS,Lin SC,Wu CW,et al.Heme oxygenase-1 gene promoter polymorphism is associated with risk of gastric adenocarcinoma and lymphovascular tumor invasion[J].Ann Surg Oncol,2007,14(8):2250-2256.
8 Kikuchi A,Yamaya M,Suzuki S,et al.Association of susceptibility to the development of lung adenocarcinoma with the heme oxygenase-1 gene promoter polymorphism[J].Hum Genet,2005,116(5):354-60.
9 Vashist YK,Uzunoglu G,Cataldegirmen G,et al.Haeme oxygenase-1 promoter polymorphism is an independent prognostic marker of gastrointestinal stromal tumour[J].Histopathology,2009,54(3):303-308.
10 Vashist YK,Uzungolu G,Kutup A,et al.Heme oxygenase-1 germ line GTn promoter polymorphism is an independent prognosticator of tumor recurrence and survival in pancreatic cancer[J].J Surg Oncol,2011,104(3):305-311.
11 Lundvig DM,Immenschuh S,Wagener FA.Heme oxygenase,inflammation,and fibrosis:the good,the bad,and the ugly?[J].Front Pharmacol,2012,3:81-94.
12 Na HK,Surh YJ.Oncogenic potential of Nrf2 and its principal target protein heme oxygenase-1[J].Free Radic Biol Med,2014,67(3):353-365.
13 Wang S,Hannafon BN,Wolf RF,et al.Characterization of docosahexaenoic acid(DHA)-induced heme oxygenase-1(HO-1)expression in human cancer cells:the importance of enhanced BTB and CNC homology 1(Bach1)degradation[J].J Nutr Biochem,2014,25(5):515-525.
14 Yin H,Fang J,Liao L,et al.Upregulation of heme oxygenase-1 in colorectal cancer patients with increased circulation carbon monoxide levels,potentially affects chemotherapeutic sensitivity[J].BMC Cancer,2014,14:436.
15 杨蕾,绕强智,赵国宏,等.HO-1在食管鳞癌转移中的作用[J].现代肿瘤医学,2013,21(11):2451-2454.
16 Wegiel B,Nemeth Z,Correa-Costa M,et al.Heme oxygenase-1:a metabolic nike[J].Antioxid Redox Signal,2014,20(11):1709-1722.
17 Kim SS,Seong S,Lim SH,et al.Biliverdin reductase plays a crucial role in hypoxia-induced chemoresistance in human glioblastoma[J].Biochem Biophys Res Commun,2013,440(4):658-663.
18 Horsfall LJ,Rait G,Walters K,et al.Serum bilirubin and risk of respiratory disease and death[J].JAMA,2011,305(7):691-697.
19 Zheng J,Nagda DA,Lajud SA,et al.Biliverdin′s regulation of reactive oxygen species signalling leads to potent inhibition of proliferative and angiogenic pathways in head and neck cancer[J].Br J Cancer,2014,110(8):2116-2122.
20 Vijayan V,Mueller S,Baumgart-Vogt E,et al.Heme oxygenase-1 as a therapeutic target in inflammatory disorders of the gastrointestinal tract[J].World J Gastroenterol,2010,16(25):3112-3119.
21 Bauer I,Pannen BH.Bench-to-bedside review:Carbon monoxide-from mitochondrial poisoning to therapeutic use[J].Crit Care,2009,13(4):220-229.
22 Liao YF,Zhu W,Li DP,et al.Heme oxygenase-1 and gut ischemia/reperfusion injury:A short review[J].World J Gastroenterol,2013,19(23):3555-3561.
23 Csongradi E,Juncos LA,Drummond HA,et al.Role of carbon monoxide in kidney function:is a little carbon monoxide good for the kidney?[J].Curr Pharm Biotechnol,2012,13(6):819-826.
24 Strasser-Weippl K,Ludwig H.Ferritin as prognostic marker in multiple myeloma patients undergoing autologous transplantation[J].Leuk Lymphoma,2014,55(11):2520-2524.
25 Torti SV,Torti FM.Iron and cancer:more ore to be mined[J].Nat Rev Cancer,2013,13(5):342-355.
26 Pogribny IP,Tryndyak VP,Pogribna M,et al.Modulation of intracellular iron metabolism by iron chelation affects chromatin remodeling proteins and corresponding epigenetic modifications in breast cancer cells and increases their sensitivity to chemotherapeutic agents[J].Int J Oncol,2013,42(5):1822-1832.
27 Aroun A,Zhong JL,Tyrrell RM,et al.Iron,oxidative stress and the example of solar ultraviolet a radiation[J].Photochem Photobiol Sci,2012,11(1):118-134.
28 Trachootham D,Alexandre J,Huang P.Targeting cancer cells by ROS-mediated mechanisms:a radical therapeutic approach?[J].Nat Rev Drug Discov,2009,8(7):579-591.
29 Sanchez-Alvarez R,Martinez-Outschoorn UE,Lin Z,et al.Ethanol exposure induces the cancer-associated fibroblast phenotype and lethal tumor metabolism:implications for breast cancer prevention[J].Cell Cycle,2013,12(2):289-301.
30 Furfaro AL,Macay JR,Marengo B,et al.Resistance of neuroblastoma GI-ME-N cell line to glutathione depletion involves Nrf2 and heme oxygenase-1[J].Free Radic Biol Med,2012,52(2):488-496.
31 Furfaro AL,Piras S,Passalacqua M,et al.HO-1 up-regulation:a key point in high-risk neuroblastoma resistance to bortezomib[J].Biochim Biophys Acta,2014,1842(4):613-622.
32 Heasman SA,Zaitseva L,Bowles KM,et al.Protection of acute myeloid leukaemia cells from apoptosis induced by front-line chemotherapeutics is mediated by haem oxygenase-1[J].Oncotarget,2011,2(9):658-668.
33 Tibullo D,Barbagallo I,Giallongo C,et al.Nuclear translocation of heme oxygenase-1 confers resistance to imatinib in chronic myeloid leukemia cells[J].Curr Pharm Des,2013,19(15):2765-2770.
34 Jeon WK,Hong HY,Seo WC,et al.Smad7 sensitizes A549 lung cancer cells to cisplatin-induced apoptosis through heme oxygenase-1 inhibition[J].Biochem Biophys Res Commun,2012,420(2):288-292.
35 Kim HR,Kim S,Kim EJ,et al.Suppression of Nrf2-driven heme oxygenase-1 enhances the chemosensitivity of lung cancer A549 cells toward cisplatin[J].Lung Cancer,2008,60(1):47-56.
36 Yun BR,Lee MJ,Kim JH,et al.Enhancement of parthenolide-induced apoptosis by a PKC-alpha inhibition through heme oxygenase-1 blockage in cholangiocarcinoma cells[J].Exp Mol Med,2010,42(11):787-797.
37 Miyake M,Fujimoto K,Anai S,et al.Inhibition of heme oxygenase-1 enhances the cytotoxic effect of gemcitabine in urothelial cancer cells[J].Anticancer Res,2010,30(6):2145-2152.
38 Yin H,Fang J,Liao L,et al.Upregulation of heme oxygenase-1 in colorectal cancer patients with increased circulation carbon monoxide levels,potentially affects chemotherapeutic sensitivity[J].BMC Cancer,2014,14:436.

[1]	孙力超,杨婧,孙立新,张媛,杨治华,冉宇靓. 采用肝癌球体细胞筛选鉴定识别肝癌干细胞的单抗[J]. 实用肿瘤学杂志, 2019, 33(3): 193-199.
[2]	张佳文,于雁,张薇,曹京燕,罗雯,尚利华. 基于UPLC-TOF/MS的小细胞肺癌患者血清代谢组学研究[J]. 实用肿瘤学杂志, 2019, 33(3): 200-205.
[3]	张茂祥,孙惠昕,宋冰冰. 2008—2012年哈尔滨市道里区恶性肿瘤发病与死亡分析[J]. 实用肿瘤学杂志, 2019, 33(3): 261-265.
[4]	刘乙澍,曲国蕃. 长链非编码RNA在骨肉瘤中的研究进展[J]. 实用肿瘤学杂志, 2019, 33(3): 266-270.
[5]	侯玉雪,李晓莉. Wnt7a与恶性肿瘤的关系及研究进展[J]. 实用肿瘤学杂志, 2019, 33(3): 271-275.
[6]	朱琳,张春霞. 纳米载药系统靶向肿瘤干细胞的研究进展[J]. 实用肿瘤学杂志, 2019, 33(3): 276-279.
[7]	徐晖, 李希, 周春水. 应用以人转录组为靶点的shRNA文库筛选肺癌肿瘤相关抑制基因[J]. 实用肿瘤学杂志, 2019, 33(2): 97-102.
[8]	李诚, 兰莉, 杨超, 张婷婷, 王蕊, 林琳, 田文静. 2015—2017年哈尔滨市恶性肿瘤发病与死亡特征分析[J]. 实用肿瘤学杂志, 2019, 33(1): 62-66.
[9]	丁界先, 张津, 陈永刚, 王兴文综述, 王栓科审校. Wnt信号通路与肿瘤发生的研究进展[J]. 实用肿瘤学杂志, 2019, 33(1): 73-77.
[10]	于芳, 赵培. TRAP1在食管癌发展中的作用及机制研究[J]. 实用肿瘤学杂志, 2018, 32(6): 515-519.
[11]	王亚龙, 吕章艳, 张帆, 冯小双, 魏锣沛, 李鑫, 温艳, 高禹舜, 薛奇, 高树庚, 谭锋维. 人乳头状瘤病毒感染与肺癌预后相关性的Meta分析[J]. 实用肿瘤学杂志, 2018, 32(6): 520-526.
[12]	唐淑丽, 何匡邦, 张纯慧, 程佳楠, 张艳桥. 胃癌组织中miR-320a和CYLD的表达及与临床病理特征及预后的关系[J]. 实用肿瘤学杂志, 2018, 32(6): 538-544.
[13]	阚钧, 周岱翰综述, 张恩欣审校. 肿瘤合并心血管疾病的研究进展[J]. 实用肿瘤学杂志, 2018, 32(6): 558-561.
[14]	顾琦晟综述, 李继坤审校. 锰超氧化物歧化酶在肿瘤发生发展过程中的研究进展[J]. 实用肿瘤学杂志, 2018, 32(6): 562-566.
[15]	刘娟综述, 张澍田审校. 细胞周期蛋白依赖性激酶抑制因子3在肿瘤中的研究进展[J]. 实用肿瘤学杂志, 2018, 32(6): 575-578.